Syngene and Johns Hopkins Partner to Advance Early-Stage Drug Discovery
Collaboration anchored in Syngene’s SynVent platform and Connector model to accelerate promising academic research
False
Collaboration anchored in Syngene’s SynVent platform and Connector model to accelerate promising academic research
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
False
False
October 15, 2026
8 min read
Advances in translational science are helping researchers better understand psychiatric disease biology, says Tanya Wallace
October 12, 2026
2 min read
“Caribou’s story has taken a heartbreaking turn,” says CEO Rachel Haurwitz, with the CRISPR-focused biotech set to discontinue vispa-cel and CB-011, and reduce its workforce
October 12, 2026
5 min read
Bayer plans a $2.2 billion Ohio campus, Genentech breaks ground in Oregon, and new investments support vaccine production, downstream processing, and manufacturing in orbit
October 8, 2026
2 min read
Adicet Bio reports 12-month remission and renal response data for its allogeneic gamma delta CAR T therapy
False
Affiliations:
Specialties:
Areas of Expertise: